B.H. Sells

744 total citations
37 papers, 643 citations indexed

About

B.H. Sells is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, B.H. Sells has authored 37 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 5 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Genetics. Recurrent topics in B.H. Sells's work include RNA and protein synthesis mechanisms (19 papers), RNA modifications and cancer (17 papers) and RNA Research and Splicing (14 papers). B.H. Sells is often cited by papers focused on RNA and protein synthesis mechanisms (19 papers), RNA modifications and cancer (17 papers) and RNA Research and Splicing (14 papers). B.H. Sells collaborates with scholars based in United States, Canada and Belgium. B.H. Sells's co-authors include Jason L. Starr, Dawn E. Larson, Peter Zahradka, Jnanankur Bag, Carlton D. Jackson, E.N. Brewer, Thillainathan Yoganathan, William E. Groves, Francis C. Davis and Marija Glibetić and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

B.H. Sells

36 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.H. Sells United States 13 529 83 49 39 35 37 643
David P. Richey United States 7 449 0.8× 74 0.9× 79 1.6× 46 1.2× 19 0.5× 8 624
J. W. Hopkins United States 11 487 0.9× 69 0.8× 59 1.2× 48 1.2× 61 1.7× 11 742
Ching-Sung Teng United States 9 591 1.1× 134 1.6× 109 2.2× 41 1.1× 45 1.3× 13 791
Thomas Kempe United States 9 359 0.7× 46 0.6× 68 1.4× 42 1.1× 32 0.9× 10 500
Jose Perdomo United States 11 464 0.9× 55 0.7× 68 1.4× 94 2.4× 34 1.0× 13 638
Yoshimasa Ike Japan 10 272 0.5× 54 0.7× 74 1.5× 28 0.7× 15 0.4× 18 438
Martin Rachmeler United States 12 485 0.9× 77 0.9× 76 1.6× 44 1.1× 52 1.5× 19 663
Kay Overgaard‐Hansen Denmark 12 339 0.6× 79 1.0× 31 0.6× 32 0.8× 32 0.9× 23 476
Sylvia J. Kerr United States 13 684 1.3× 45 0.5× 48 1.0× 30 0.8× 18 0.5× 31 880
Theodore C. Y. Lo Canada 17 514 1.0× 119 1.4× 37 0.8× 116 3.0× 48 1.4× 44 737

Countries citing papers authored by B.H. Sells

Since Specialization
Citations

This map shows the geographic impact of B.H. Sells's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.H. Sells with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.H. Sells more than expected).

Fields of papers citing papers by B.H. Sells

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.H. Sells. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.H. Sells. The network helps show where B.H. Sells may publish in the future.

Co-authorship network of co-authors of B.H. Sells

This figure shows the co-authorship network connecting the top 25 collaborators of B.H. Sells. A scholar is included among the top collaborators of B.H. Sells based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.H. Sells. B.H. Sells is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoganathan, Thillainathan, M Horikoshi, Robert G. Roeder, & B.H. Sells. (1993). Direct binding of yeast transcription factor (TFIID) to the ribosomal protein L32 (rpL32) TATA‐less promoter sequence. FEBS Letters. 326(1-3). 163–166. 8 indexed citations
2.
Larson, Dawn E., Ingrid Hoffmann, Peter Zahradka, Max L. Birnstiel, & B.H. Sells. (1992). Histone H4 mRNA levels are down-regulated by 3′ RNA processing during terminal differentiation of myoblasts. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1131(2). 139–144. 4 indexed citations
3.
Welsh, Eric A., Peter Zahradka, Dawn E. Larson, B.H. Sells, & George Harauz. (1992). Visualization of a mammalian transcription initiation complex. Biochemistry and Cell Biology. 70(5). 291–300. 1 indexed citations
4.
Yoganathan, Thillainathan, M Horikoshi, S. Hasegawa, Robert G. Roeder, & B.H. Sells. (1992). Yeast transcription factor IID participates in cell-free transcription of a mammalian ribosomal protein TATA-less promoter. Biochemical Journal. 285(3). 721–723. 11 indexed citations
5.
Yoganathan, Thillainathan, N K Bhat, & B.H. Sells. (1992). A positive regulator of the ribosomal protein gene, β factor, belongs to the ETS oncoprotein family. Biochemical Journal. 287(2). 349–353. 25 indexed citations
6.
Larson, Dawn E., Peter Zahradka, & B.H. Sells. (1991). Control points in eucaryotic ribosome biogenesis. Biochemistry and Cell Biology. 69(1). 5–22. 77 indexed citations
7.
Adachi, Kei, et al.. (1980). Synthesis of ribosomal protein S1 following nutritional shift-up in Escherichia coli K-12.. Journal of Biological Chemistry. 255(2). 357–360. 4 indexed citations
8.
Sells, B.H., et al.. (1976). Molecular morphology of ribosomes: Effect of chain initiation factor 3 on 30 S subunit conformation. FEBS Letters. 71(2). 347–350. 13 indexed citations
9.
Sells, B.H., et al.. (1971). Ribosomal protein synthesis during recovery from puromycin treatment. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 232(4). 736–740. 2 indexed citations
10.
Davis, Francis C. & B.H. Sells. (1971). Biogenesis of 30-S subunits in exponentially growing Escherichia coli. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 232(2). 379–387. 5 indexed citations
11.
Sells, B.H., et al.. (1971). Cellulase Induction During Standardized Vegetative Growth in Achlya. Journal of General Microbiology. 67(3). 367–369. 1 indexed citations
12.
Groves, William E. & B.H. Sells. (1969). Preparation of growth hormone from a rat mammosomatotropic pituitary tumor.. PubMed. 29(2). 409–13. 1 indexed citations
13.
Groves, William E. & B.H. Sells. (1968). Purification of rat prolactin and growth hormone using preparative polyacrylamide gel electrophoresis. Biochimica et Biophysica Acta (BBA) - Protein Structure. 168(1). 113–121. 10 indexed citations
14.
Groves, William E., Francis C. Davis, & B.H. Sells. (1968). An automatic device for sectioning analytical polyacrylamide gels: Radioactive Escherichia coli 50 S ribosomal proteins. Analytical Biochemistry. 24(3). 462–469. 15 indexed citations
15.
Jackson, Carlton D. & B.H. Sells. (1968). Countercurrent distribution of RNA from rat liver: Effect of growth hormone, thyroxine, and hydrocortisone on distribution patterns. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 155(2). 417–423. 10 indexed citations
16.
Sells, B.H., et al.. (1966). Ribosome production during recovery from puromycin treatment: Influence of 5-fluorouracil. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 123(2). 253–264. 8 indexed citations
17.
Sells, B.H.. (1966). Ribosome formation from ribonucleic acid accumulated during puromycin treatment: Influence of proflavin. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 114(3). 565–577. 9 indexed citations
18.
Sells, B.H., et al.. (1961). The influence of the nucleus upon adenosine triphosphatase activity in Amoeba proteus. Experimental Cell Research. 22. 246–256. 10 indexed citations
19.
Sells, B.H.. (1960). The effect of thymidine upon the incorporation of uracil into Bacillus cereus. Biochimica et Biophysica Acta. 40. 548–549. 2 indexed citations
20.
Sells, B.H.. (1959). Influence of 6-azauracil on the metabolism of Bacillus cereus. Biochemical Pharmacology. 2(4). 255–263. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David P. Richey Breakdown of academic impact, for papers by J. W. Hopkins Breakdown of academic impact, for papers by Ching-Sung Teng Breakdown of academic impact, for papers by Thomas Kempe Breakdown of academic impact, for papers by Jose Perdomo Breakdown of academic impact, for papers by Yoshimasa Ike Breakdown of academic impact, for papers by Martin Rachmeler Breakdown of academic impact, for papers by Kay Overgaard‐Hansen Breakdown of academic impact, for papers by Sylvia J. Kerr Breakdown of academic impact, for papers by Theodore C. Y. Lo
Rankless by CCL
2026